Abbott Laboratories is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business at the beginning of 2013.

The UK's FTSE 100 remained largely unchanged on Friday, as losses in major financial stocks counterbalanced gains in energy shares.